Skip to main content

Table 1 Correlation between SLC39A1 and 22 subtypes of immune cell in glioma samples

From: SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas

Inmune cells

Cor

P

Macrophages M2

0.336

< 0.001

Macrophages M0

0.309

< 0.001

Eosinophils

0.261

< 0.001

T cells regulatory (Tregs)

0.195

< 0.001

T cells gamma delta

0.18

< 0.001

Macrophages M1

0.093

0.013

T cells CD4 memory activated

0.081

0.032

Dendritic cells activated

0.067

0.076

NK cells resting

0.053

0.16

T cells CD4 memory resting

0.051

0.18

Neutrophils

0.022

0.564

T cells CD8

−0.033

0.384

Plasma cells

−0.039

0.305

Dendritic cells resting

−0.049

0.192

B cells naive

−0.094

0.012

B cells memory

−0.101

0.007

Mast cells resting

−0.18

< 0.001

T cells follicular helper

−0.181

< 0.001

Monocytes

−0.193

< 0.001

Mast cells activated

−0.211

< 0.001

T cells CD4 naive

−0.24

< 0.001

NK cells activated

−0.268

< 0.001